Ron Bentsur
2010 - Keryx Biopharmaceuticals
In 2010, Ron Bentsur earned a total compensation of $1.4M as Chief Executive Officer at Keryx Biopharmaceuticals, a 97% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $175,000 |
|---|---|
| Option Awards | $251,829 |
| Salary | $300,000 |
| Stock Awards | $710,000 |
| Total | $1,436,829 |
Bentsur received $710K in stock awards, accounting for 49% of the total pay in 2010.
Bentsur also received $175K in non-equity incentive plan, $251.8K in option awards and $300K in salary.
Rankings
In 2010, Ron Bentsur's compensation ranked 4,093rd out of 10,439 executives tracked by ExecPay. In other words, Bentsur earned more than 60.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,093 out of 10,439 | 61st |
Division Manufacturing | 1,445 out of 3,838 | 62nd |
Major group Chemicals And Allied Products | 285 out of 926 | 69th |
Industry group Drugs | 157 out of 685 | 77th |
Industry Pharmaceutical Preparations | 123 out of 481 | 74th |
Source: SEC filing on April 30, 2013.
Bentsur's colleagues
We found one more compensation record of an executive who worked with Ron Bentsur at Keryx Biopharmaceuticals in 2010.
2010
James Oliviero
Keryx Biopharmaceuticals